お知らせ
-
Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C
Takasuke Fukuhara, Akinobu Taketomi, Takashi Motomura, … 続きを読む
-
Impact of preoperative serum sodium concentration in living donor liver transplantation
Takasuke Fukuhara, Toru Ikegami, Kazutoyo Morita, Kenji… 続きを読む
-
Improved results for a surgical resection for the recurrence of hepatocellular carcinoma after living donor liver transplantation
Akinobu Taketomi, Takasuke Fukuhara, Kazutoyo Morita, H… 続きを読む
-
Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation
Takasuke Fukuhara, Akinobu Taketomi, Shinji Okano, Toru… 続きを読む
-
Impact of amino acid substitutions in the core region of HCV on multistep hepatocarcinogenesis
Takasuke Fukuhara, Kazuki Takeishi, Takeo Toshima, Kazu… 続きを読む
-
The benefits of interferon treatment in patients without sustained viral response after living donor liver transplantation for hepatitis C
T Ikegami, A Taketomi, Y Soejima, T Yoshizumi, T Fukuha… 続きを読む
-
De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation
Kazutoyo Morita, Akinobu Taketomi, Yuji Soejima, Toru I… 続きを読む
-
Human VAP-C negatively regulates hepatitis C virus propagation
Hiroshi Kukihara, Kohji Moriishi, Shuhei Taguwa, Hideki… 続きを読む
-
Congestion of the donor remnant right liver after extended left lobe donation.
Takasuke Fukuhara, Kenji Umeda, Takeo Toshima, Kazuki T… 続きを読む
-
Phase1/2 study of the lipiodolization using DDP-H (CDDP powder; IA-call) in patients with unresectable hepatocellular carcinoma
Yo-ichi Yamashita, Akinobu Taketomi, Shinji Itoh, Norif… 続きを読む
